Kingworld Medicines Group's quarterly market cap
declined
from Dec. 2022 (HK$529 Mil) to Jun. 2023 (HK$380 Mil) but then
increased
from Jun. 2023 (HK$380 Mil) to Dec. 2023 (HK$392 Mil).
Kingworld Medicines Group's annual market cap
increased
from Dec. 2021 (HK$473 Mil) to Dec. 2022 (HK$529 Mil) but then
declined
from Dec. 2022 (HK$529 Mil) to Dec. 2023 (HK$392 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kingworld Medicines Group's Enterprise Value for Today is HK$575 Mil.
Kingworld Medicines Group Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kingworld Medicines Group's Market Cap
For the Pharmaceutical Retailers subindustry, Kingworld Medicines Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kingworld Medicines Group's Market Cap Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Kingworld Medicines Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Kingworld Medicines Group's Market Cap falls into.
Kingworld Medicines Group Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kingworld Medicines Group (HKSE:01110) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Kingworld Medicines Group Market Cap Related Terms
Thank you for viewing the detailed overview of Kingworld Medicines Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Kingworld Medicines Group (HKSE:01110) Business Description
Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01110 has been successfully added to your 